Antimicrobial drug-induced thrombocytopenia: A review of the literature

Angela S. Loo, Lana Gerzenshtein, Michaelg Ison*

*Corresponding author for this work

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The incidence of drug-induced thrombocytopenia (DIT) is not well-defined, but is estimated to occur at a minimum of 10 cases per million per year. This review will focus on the potential DIT associated with specific antibacterial, antifungal, antiviral, and antiparasitic agents. Case reports, cohort studies, and clinical trials were identified using PubMed search terms for each antimicrobial along with the Boolean combiner AND to match with the following outcomes: thrombocytopenia and bleed. Thrombocytopenia was defined as a platelet count of < 100 × 109/L or a decrease in platelet count of at least 50% from baseline. A majority of the data supporting antimicrobial-induced thrombocytopenia consist of case reports and small studies. However, clinicians should be vigilant in monitoring patient platelet counts, as an immune-mediated mechanism is frequently responsible for this hematologic adverse effect and is therefore unpredictable.

Original languageEnglish (US)
Pages (from-to)818-829
Number of pages12
JournalSeminars in Thrombosis and Hemostasis
Volume38
Issue number8
DOIs
StatePublished - Oct 22 2012

Fingerprint

Thrombocytopenia
Platelet Count
Pharmaceutical Preparations
Antiparasitic Agents
Antifungal Agents
Physiologic Monitoring
PubMed
Antiviral Agents
Cohort Studies
Clinical Trials
Anti-Bacterial Agents
Incidence

Keywords

  • antimicrobials
  • coagulopathy
  • thrombocytopenia

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

@article{5bcd0e3d65284f87a66d6f262de19321,
title = "Antimicrobial drug-induced thrombocytopenia: A review of the literature",
abstract = "The incidence of drug-induced thrombocytopenia (DIT) is not well-defined, but is estimated to occur at a minimum of 10 cases per million per year. This review will focus on the potential DIT associated with specific antibacterial, antifungal, antiviral, and antiparasitic agents. Case reports, cohort studies, and clinical trials were identified using PubMed search terms for each antimicrobial along with the Boolean combiner AND to match with the following outcomes: thrombocytopenia and bleed. Thrombocytopenia was defined as a platelet count of < 100 × 109/L or a decrease in platelet count of at least 50{\%} from baseline. A majority of the data supporting antimicrobial-induced thrombocytopenia consist of case reports and small studies. However, clinicians should be vigilant in monitoring patient platelet counts, as an immune-mediated mechanism is frequently responsible for this hematologic adverse effect and is therefore unpredictable.",
keywords = "antimicrobials, coagulopathy, thrombocytopenia",
author = "Loo, {Angela S.} and Lana Gerzenshtein and Michaelg Ison",
year = "2012",
month = "10",
day = "22",
doi = "10.1055/s-0032-1328882",
language = "English (US)",
volume = "38",
pages = "818--829",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "8",

}

Antimicrobial drug-induced thrombocytopenia : A review of the literature. / Loo, Angela S.; Gerzenshtein, Lana; Ison, Michaelg.

In: Seminars in Thrombosis and Hemostasis, Vol. 38, No. 8, 22.10.2012, p. 818-829.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antimicrobial drug-induced thrombocytopenia

T2 - A review of the literature

AU - Loo, Angela S.

AU - Gerzenshtein, Lana

AU - Ison, Michaelg

PY - 2012/10/22

Y1 - 2012/10/22

N2 - The incidence of drug-induced thrombocytopenia (DIT) is not well-defined, but is estimated to occur at a minimum of 10 cases per million per year. This review will focus on the potential DIT associated with specific antibacterial, antifungal, antiviral, and antiparasitic agents. Case reports, cohort studies, and clinical trials were identified using PubMed search terms for each antimicrobial along with the Boolean combiner AND to match with the following outcomes: thrombocytopenia and bleed. Thrombocytopenia was defined as a platelet count of < 100 × 109/L or a decrease in platelet count of at least 50% from baseline. A majority of the data supporting antimicrobial-induced thrombocytopenia consist of case reports and small studies. However, clinicians should be vigilant in monitoring patient platelet counts, as an immune-mediated mechanism is frequently responsible for this hematologic adverse effect and is therefore unpredictable.

AB - The incidence of drug-induced thrombocytopenia (DIT) is not well-defined, but is estimated to occur at a minimum of 10 cases per million per year. This review will focus on the potential DIT associated with specific antibacterial, antifungal, antiviral, and antiparasitic agents. Case reports, cohort studies, and clinical trials were identified using PubMed search terms for each antimicrobial along with the Boolean combiner AND to match with the following outcomes: thrombocytopenia and bleed. Thrombocytopenia was defined as a platelet count of < 100 × 109/L or a decrease in platelet count of at least 50% from baseline. A majority of the data supporting antimicrobial-induced thrombocytopenia consist of case reports and small studies. However, clinicians should be vigilant in monitoring patient platelet counts, as an immune-mediated mechanism is frequently responsible for this hematologic adverse effect and is therefore unpredictable.

KW - antimicrobials

KW - coagulopathy

KW - thrombocytopenia

UR - http://www.scopus.com/inward/record.url?scp=84868517825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868517825&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1328882

DO - 10.1055/s-0032-1328882

M3 - Article

C2 - 23081819

AN - SCOPUS:84868517825

VL - 38

SP - 818

EP - 829

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 8

ER -